Fact based stock research
Symrise (XTRA:SY1)

DE000SYM9999

Symrise stock research in summary

symrise.com


Symrise shares are more expensive than other comparable stocks. While they are safely financed, they show below average growth, and are poor value. We recommend evaluating whether the future of the company Symrise is really as positive as the high price of the shares suggests. If you come to the conclusion that the future for this company is only average, that could be a reason to sell this share.


Latest Obermatt Ranks


Country Germany
Industry Specialty Chemicals
Index CDAX, DAX 40, MDAX
Size class X-Large

June 2, 2022. Stock data may be delayed. Login to get the most recent research.



Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Symrise from June 2, 2022.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.